Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Breast Carcinoma”

606 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 606 results

Not applicableLooking for participantsNCT06633276
What this trial is testing

Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing)

Who this might be right for
Breast Cancer Invasive
University of Bonn 100
Not applicableEnded earlyNCT03560102
What this trial is testing

Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer

Who this might be right for
Breast Cancer, Invasive Ductal
Kantonsspital Winterthur KSW 1
Testing effectiveness (Phase 2)Looking for participantsNCT04569747
What this trial is testing

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerInvasive Carcinoma of the BreastBreast Cancer+3 more
Dana-Farber Cancer Institute 375
Testing effectiveness (Phase 2)Ended earlyNCT01319539
What this trial is testing

MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+11 more
National Cancer Institute (NCI) 12
Not applicableLooking for participantsNCT06401304
What this trial is testing

Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)

Who this might be right for
Breast CancerBreast Carcinoma in SituBreast Cancer Invasive+1 more
Uppsala University 1,200
Not applicableStudy completedNCT07052734
What this trial is testing

Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients

Who this might be right for
Breast Cancer
Sun Yat-sen University 2,843
Testing effectiveness (Phase 2)Active Not RecruitingNCT03756298
What this trial is testing

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
National Cancer Center, Korea 284
Not applicableStudy completedNCT02773784
What this trial is testing

Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.

Who this might be right for
Invasive Breast Cancer
Peking University 314
Not applicableStudy completedNCT04999917
What this trial is testing

Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer

Who this might be right for
Breast CancerBreast Cancer InvasiveBreast Cancer in Situ
XEOS Medical 206
Not applicableActive Not RecruitingNCT07044791
What this trial is testing

Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer

Who this might be right for
Breast CancerBreast Cancer Invasive
Federico II University 120
Not applicableLooking for participantsNCT05318274
What this trial is testing

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Who this might be right for
Ductal Breast Carcinoma in SituInvasive Breast CancerEarly-stage Breast Cancer+4 more
Coordinación de Investigación en Salud, Mexico 72
Early research (Phase 1)Ended earlyNCT01816555
What this trial is testing

Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma

Who this might be right for
Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II
Medical University of South Carolina 1
Not applicableActive Not RecruitingNCT06499077
What this trial is testing

Non-invasive Detection of Breast Cancer by Breath Analysis

Who this might be right for
Breast Neoplasm Female
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 1,000
Not applicableStudy completedNCT00602628
What this trial is testing

Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 60
Testing effectiveness (Phase 2)Looking for participantsNCT06677944
What this trial is testing

Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in SituInvasive Breast Cancer
Yonsei University 47
Not applicableStudy completedNCT01508273
What this trial is testing

Lifestyle Intervention for High Risk Cancer Survivors

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1,150
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT05960201
What this trial is testing

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

Who this might be right for
Carcinoma, Lobular
Asan Medical Center 23
Large-scale testing (Phase 3)Active Not RecruitingNCT04622319
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

Who this might be right for
HER2-Positive Primary Breast CancerResidual Invasive Breast Cancer
Daiichi Sankyo 1,600
Early research (Phase 1)Study completedNCT00290732
What this trial is testing

Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Load More Results